SHAREHOLDERS' DEFICIT

3 Months Ended

Mar. 24, 2021

Stockholders' Equity Note [Abstract]

The changes in Total shareholders’ deficit during the thirty-nine week periods ended March 24, 2021 and March 25, 2020, respectively, were as follows:


	Thirty-Nine Week Period Ended March 24, 2021
	Common Stock		Additional Paid-In Capital		Accumulated Deficit		Treasury Stock		Accumulated Other Comprehensive Loss		Total
Balance at June 24, 2020	$	7.0	$	669.4	$	(397.5)	$	(751.8)	$	(6.2)	$	(479.1)
Net income	—		—		10.7		—		—		10.7
Other comprehensive income	—		—		—		—		0.3		0.3
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		3.9		—		—		—		3.9
Purchases of treasury stock	—		(1.1)		—		(2.8)		—		(3.9)
Issuances of common stock	—		(9.0)		—		12.0		—		3.0
Balance at September 23, 2020	$	7.0	$	663.2	$	(386.8)	$	(742.6)	$	(5.9)	$	(465.1)
Net income	—		—		12.0		—		—		12.0
Other comprehensive income	—		—		—		—		0.5		0.5
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		3.0		—		—		—		3.0
Purchases of treasury stock	—		0.0		—		0.0		—		0.0
Issuances of common stock	—		1.2		—		4.3		—		5.5

Balance at December 23, 2020	$	7.0	$	667.4	$	(374.8)	$	(738.3)	$	(5.4)	$	(444.1)
Net income	—		—		33.9		—		—		33.9
Other comprehensive income	—		—		—		—		0.3		0.3
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		4.4		—		—		—		4.4
Purchases of treasury stock	—		(0.1)		—		(0.1)		—		(0.2)
Issuances of common stock	—		5.7		—		9.4		—		15.1
Balance at March 24, 2021	$	7.0	$	677.4	$	(340.9)	$	(729.0)	$	(5.1)	$	(390.6)


	Thirty-Nine Week Period Ended March 25, 2020
	Common Stock		Additional Paid-In Capital		Retained Earnings (Accumulated Deficit)		Treasury Stock		Accumulated Other Comprehensive Loss		Total
Balance at June 26, 2019	$	17.6	$	522.0	$	2,771.2	$	(4,083.4)	$	(5.6)	$	(778.2)
Effect of ASC 842 adoption	—		—		195.9		—		—		195.9
Net income	—		—		14.9		—		—		14.9
Other comprehensive loss	—		—		—		—		(0.2)		(0.2)
Dividends ($0.38 per share)	—		—		(14.6)		—		—		(14.6)
Stock-based compensation	—		7.1		—		—		—		7.1
Purchases of treasury stock	—		(0.3)		—		(11.0)		—		(11.3)
Issuances of common stock	—		(3.7)		—		5.0		—		1.3
Balance at September 25, 2019	$	17.6	$	525.1	$	2,967.4	$	(4,089.4)	$	(5.8)	$	(585.1)
Net income	—		—		27.9		—		—		27.9
Other comprehensive income	—		—		—		—		0.1		0.1
Dividends ($0.38 per share)	—		—		(14.6)		—		—		(14.6)
Stock-based compensation	—		2.6		—		—		—		2.6
Purchases of treasury stock	—		0.0		—		0.0		—		0.0
Issuances of common stock	—		(0.4)		—		0.6		—		0.2
Retirement of treasury stock	(11.4)		—		(3,345.4)		3,356.8		—		—
Balance at December 25, 2019	$	6.2	$	527.3	$	(364.7)	$	(732.0)	$	(5.7)	$	(568.9)
Net income	—		—		30.8		—		—		30.8
Other comprehensive loss	—		—		—		—		(1.0)		(1.0)
Dividends ($0.38 per share)	—		—		(14.0)		—		—		(14.0)
Stock-based compensation	—		(0.7)		—		—		—		(0.7)
Purchases of treasury stock	—		0.0		—		(21.0)		—		(21.0)
Issuances of common stock	—		(0.5)		—		0.6		—		0.1
Balance at March 25, 2020	$	6.2	$	526.1	$	(347.9)	$	(752.4)	$	(6.7)	$	(574.7)

Dividends

In the fourth quarter of fiscal 2020, our Board of Directors voted to suspend the quarterly cash dividend in response to liquidity needs created by the COVID-19 pandemic. Before this suspension, we paid dividends of $0.38 per share quarterly. In the thirty-nine week period ended March 24, 2021, dividends paid were solely related to the previously accrued dividends for restricted share awards that vested in the period. Restricted share award dividends are accrued in Other accrued liabilities for the current portion to vest within 12 months, and Other liabilities for the portion that will vest after one year. In the thirty-nine week period ended March 25, 2020, we paid dividends of $43.3 million to common stock shareholders.

Stock-based Compensation

The following table presents the stock options and restricted share awards granted, and related weighted average exercise price and fair value per share amounts.


	Thirty-Nine Week Periods Ended
	March 24, 2021		March 25, 2020
Stock options
Stock options granted	—		0.3
Weighted average exercise price per share	$	—	$	38.51
Weighted average fair value per share	$	—	$	6.83
Restricted share awards
Restricted share awards granted	0.5		0.3
Weighted average fair value per share	$	40.49	$	38.68

Share Repurchases

In the fourth quarter of fiscal 2020, our share repurchase program was suspended in response to the business downturn caused by the COVID-19 pandemic. Prior to the suspension, our share repurchase program was used to return capital to shareholders and to minimize the dilutive impact of stock options and other share-based awards. We evaluated potential share repurchases under our plan based on several factors, including our cash position, share price, operational liquidity, proceeds from divestitures, borrowings, and planned investment and financing needs. Repurchased shares are reflected as an increase in Treasury stock within Shareholders’ deficit in the Consolidated Balance Sheets (Unaudited).

In the thirty-nine week period ended March 24, 2021, we repurchased 0.1 million shares from team members to satisfy tax withholding obligations on the vesting of restricted shares. Before the suspension of our repurchase program, in the thirty-nine week period ended March 25, 2020, we repurchased 0.8 million shares of our common stock for $32.3 million.

Effect of Adoption of ASC 842

In the first quarter of fiscal 2020, we adopted the lease accounting standard, ASC 842, and recorded a $195.9 million cumulative effect adjustment to Retained earnings (accumulated deficit) for the change in accounting principle.

Retirement of Treasury Stock

In the second quarter of fiscal 2020, the Board of Directors approved the retirement of 114 million shares of Treasury stock for a weighted average price per share of $29.45.